TY - JOUR
T1 - The Role of Gut Microbiota in the High-Risk Construct of Severe Mental Disorders
T2 - A Mini Review
AU - Sani, Gabriele
AU - Manchia, Mirko
AU - Simonetti, Alessio
AU - Janiri, Delfina
AU - Paribello, Pasquale
AU - Pinna, Federica
AU - Carpiniello, Bernardo
N1 - Funding Information:
This paper was partly funded by Fondo Integrativo per la Ricerca (FIR)-2019 granted to MM, FP, and BC.
Publisher Copyright:
© Copyright © 2021 Sani, Manchia, Simonetti, Janiri, Paribello, Pinna and Carpiniello.
PY - 2021/1/12
Y1 - 2021/1/12
N2 - Severe mental disorders (SMD) are highly prevalent psychiatric conditions exerting an enormous toll on society. Therefore, prevention of SMD has received enormous attention in the last two decades. Preventative approaches are based on the knowledge and detailed characterization of the developmental stages of SMD and on risk prediction. One relevant biological component, so far neglected in high risk research, is microbiota. The human microbiota consists in the ensemble of microbes, including viruses, bacteria, and eukaryotes, that inhabit several ecological niches of the organism. Due to its demonstrated role in modulating illness and health, as well in influencing behavior, much interest has focused on the characterization of the microbiota inhabiting the gut. Several studies in animal models have shown the early modifications in the gut microbiota might impact on neurodevelopment and the onset of deficits in social behavior corresponding to distinct neurosignaling alterations. However, despite this evidence, only one study investigated the effect of altered microbiome and risk of developing mental disorders in humans, showing that individuals at risk for SMD had significantly different global microbiome composition than healthy controls. We then offer a developmental perspective and provided mechanistic insights on how changes in the microbiota could influence the risk of SMD. We suggest that the analysis of microbiota should be included in the comprehensive assessment generally performed in populations at high risk for SMD as it can inform predictive models and ultimately preventative strategies.
AB - Severe mental disorders (SMD) are highly prevalent psychiatric conditions exerting an enormous toll on society. Therefore, prevention of SMD has received enormous attention in the last two decades. Preventative approaches are based on the knowledge and detailed characterization of the developmental stages of SMD and on risk prediction. One relevant biological component, so far neglected in high risk research, is microbiota. The human microbiota consists in the ensemble of microbes, including viruses, bacteria, and eukaryotes, that inhabit several ecological niches of the organism. Due to its demonstrated role in modulating illness and health, as well in influencing behavior, much interest has focused on the characterization of the microbiota inhabiting the gut. Several studies in animal models have shown the early modifications in the gut microbiota might impact on neurodevelopment and the onset of deficits in social behavior corresponding to distinct neurosignaling alterations. However, despite this evidence, only one study investigated the effect of altered microbiome and risk of developing mental disorders in humans, showing that individuals at risk for SMD had significantly different global microbiome composition than healthy controls. We then offer a developmental perspective and provided mechanistic insights on how changes in the microbiota could influence the risk of SMD. We suggest that the analysis of microbiota should be included in the comprehensive assessment generally performed in populations at high risk for SMD as it can inform predictive models and ultimately preventative strategies.
KW - alpha diversity
KW - animal models
KW - autism spectrum disorder
KW - depression
KW - genomics
KW - microbiome
KW - schizophrenia
KW - Shannon index
UR - http://www.scopus.com/inward/record.url?scp=85100022296&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100022296&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2020.585769
DO - 10.3389/fpsyt.2020.585769
M3 - Review article
AN - SCOPUS:85100022296
SN - 1664-0640
VL - 11
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 585769
ER -